REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

PT Nulab Pharmaceutical Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Nulab Pharmaceutical Indonesia Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Nulab Pharmaceutical Indonesia is a pharmaceutical company that specializes in the production and distribution of generics and branded generic pharmaceutical products, with a focus on pharmakovigilans activities.

Headquarters
Komplek Green Ville Maisonette Blok FB No. 5-6
West Jakarta; Jakarta; Postal Code: 11510

Contact Details: Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.

Website: http://www.nulabpharmaceutical.com

Basic Information
Total Employees:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Registered Capital:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Incorporation Date:
October 17, 2008
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Nulab Pharmaceutical Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1.52%▲
Total operating revenue
1.52%▲
Total assets
2.04%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo